SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-024490
Filing Date
2022-11-10
Accepted
2022-11-10 16:18:25
Documents
68
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q elox-20220930.htm   iXBRL 10-Q 2771990
2 EX-31.1 elox-ex31_1.htm EX-31.1 17973
3 EX-31.2 elox-ex31_2.htm EX-31.2 19224
4 EX-32.1 elox-ex32_1.htm EX-32.1 9566
5 EX-32.2 elox-ex32_2.htm EX-32.2 9720
  Complete submission text file 0000950170-22-024490.txt   7980685

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT elox-20220930_lab.xml EX-101.LAB 364062
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT elox-20220930_pre.xml EX-101.PRE 268824
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT elox-20220930_cal.xml EX-101.CAL 52942
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT elox-20220930_def.xml EX-101.DEF 122174
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT elox-20220930.xsd EX-101.SCH 46996
62 EXTRACTED XBRL INSTANCE DOCUMENT elox-20220930_htm.xml XML 1326492
Mailing Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472 781-577-5300
Eloxx Pharmaceuticals, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31326 | Film No.: 221377498
SIC: 2836 Biological Products, (No Diagnostic Substances)